{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T20:48:44Z","timestamp":1701982124347},"reference-count":21,"publisher":"Cambridge University Press (CUP)","issue":"S1","license":[{"start":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T00:00:00Z","timestamp":1484265600000},"content-version":"unspecified","delay-in-days":12,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["www.cambridge.org"],"crossmark-restriction":true},"short-container-title":["Cardiol Young"],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Improved public awareness and advances in medical diagnostics have resulted in the development of criteria to determine eligibility or disqualification for the athlete with cardiovascular abnormalities. Simultaneously, protocols have been developed for athletes with concussion or orthopaedic injuries to guide team physicians and consultants in return-to-play decisions. However, there are currently inadequate data to allow the development of such protocols for athletes with cardiovascular abnormalities who have undergone treatment. Further complicating the decision process is the designation of the team physician as the ultimate authority in making return-to-play decisions \u2013 where the team physician often is an employee of the team and supports the team\u2019s goal and players as well as the individual athlete. This review will discuss the ethical dilemma of the team physician and the role of the cardiovascular consultant. Following this, current data and practices regarding return to play will be discussed for the following conditions or diagnoses: following catheter ablation for supraventricular tachycardia; following pacemaker or implantable cardioverter-defibrillator implantation; unexplained syncope; and the athlete with a genetic mutation in the absence of any phenotype of associated disease. These recommendations will undoubtedly continue to evolve and improve and should be considered at this time as a point of departure.<\/jats:p>","DOI":"10.1017\/s104795111600233x","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T14:53:36Z","timestamp":1484319216000},"page":"S110-S114","update-policy":"http:\/\/dx.doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":2,"title":["Return to play in the athlete with cardiac disease: who decides and what is the protocol?"],"prefix":"10.1017","volume":"27","author":[{"given":"Michael J.","family":"Silka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2017,1,13]]},"reference":[{"key":"S104795111600233X_ref16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/01.hjr.0000216543.54066.72","article-title":"Recommendations for participation in leisure-time physical activities and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions. Part 1: supraventricular arrhythmias and pacemakers","volume":"13","author":"Heidbucchel","year":"2006","journal-title":"Eur J Card Prevent and Rehab"},{"key":"S104795111600233X_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.09.041"},{"key":"S104795111600233X_ref17","first-page":"S95","article-title":"Activity recommendations in paced pediatric patients. Wide variations among practitioners","volume":"5","author":"Gajewski","year":"2008","journal-title":"Heart Rhythm"},{"key":"S104795111600233X_ref3","doi-asserted-by":"publisher","DOI":"10.1249\/JSR.0b013e3182159a55"},{"key":"S104795111600233X_ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.02.014"},{"key":"S104795111600233X_ref9","unstructured":"Parsons JT. 2014-2015 NCAA Sports Medicine Handbook, 2014. Retrieved 16 April 2016 from https:\/\/www.ncaapublications.com\/p-4374-2013-14-ncaa-sports-medicine-handbook.aspx."},{"key":"S104795111600233X_ref6","unstructured":"Mobley v Madison Square Garden LP, 2013 US Dist LEXIS (SD New York 2012)."},{"key":"S104795111600233X_ref8","doi-asserted-by":"publisher","DOI":"10.1080\/15265161.2013.828114"},{"key":"S104795111600233X_ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.09.042"},{"key":"S104795111600233X_ref18","unstructured":"National Heart, Lung, and Blood Institute. Implantable cardioverter defibrillator. 2016. Retrieved February 13, 2016, from http:\/\/www.nhlbi.nih.gov\/health\/dci\/Diseases\/icd\/icd_all.html."},{"key":"S104795111600233X_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.09.047"},{"key":"S104795111600233X_ref21","first-page":"93","article-title":"Preventing sudden death on the athletic field: the emergency action plan","volume":"6","author":"Courson","year":"2007","journal-title":"Curr Sports Med Rep"},{"key":"S104795111600233X_ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2013-093023"},{"key":"S104795111600233X_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2008.01.024"},{"key":"S104795111600233X_ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp0803964"},{"key":"S104795111600233X_ref11","doi-asserted-by":"publisher","DOI":"10.1080\/21622965.2013.791825"},{"key":"S104795111600233X_ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811263392211"},{"key":"S104795111600233X_ref7","doi-asserted-by":"publisher","DOI":"10.4085\/1062-6050-50.6.03"},{"key":"S104795111600233X_ref10","doi-asserted-by":"publisher","DOI":"10.1123\/JSR.2013-0009"},{"key":"S104795111600233X_ref13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi325"},{"key":"S104795111600233X_ref1","first-page":"2250","article-title":"Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: preamble, principles and general considerations","volume":"66","author":"Maron","year":"2015","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiology in the Young"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S104795111600233X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T19:10:20Z","timestamp":1555614620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S104795111600233X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":21,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S104795111600233X"],"URL":"https:\/\/doi.org\/10.1017\/s104795111600233x","relation":{},"ISSN":["1047-9511","1467-1107"],"issn-type":[{"value":"1047-9511","type":"print"},{"value":"1467-1107","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"\u00a9 Cambridge University Press 2017\u00a0","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}